Thermo Fisher Scientific Reports Second Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Pentagon reportedly locked down, hazmat teams responding
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Thermo Fisher Scientific (TMO) PT Raised to $260 at Deutsche Bank
July 25, 2018 1:57 PM EDTDeutsche Bank raised its price target on Thermo Fisher Scientific (NYSE: TMO) to $260.00 (from $245.00) while maintaining a Buy rating following results.
Analyst Dan Leonard said TMO's upwardly revised organic sales growth guidance of 6% appears conservative. End markets were robust, led by China and biopharma.
... MoreThermo Fisher Scientific (TMO) Tops Q2 EPS by 13c, Revenues Beat; Boosts FY18 EPS/Revenue Outlook
July 25, 2018 6:03 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $2.75, $0.13 better than the analyst estimate of $2.62. Revenue for the quarter came in at $6.08 billion versus the consensus estimate of $5.89 billion.
Second Quarter 2018 Highlights
Grew revenue 22% to $6.08 billion.Increased GAAP diluted earnings per share (EPS) 19% to $1.85.Increased adjusted EPS 20% to $2.75.Launched suite of new mass spectrometry systems for life sciences and applied markets highlighted by the Thermo Scientific Q Exactive UHMR for protein research as well as new products for clinical research and diagnostics, including the Ion Torrent... More